Transfusion Technology Market (By Product: Instruments [Apheresis System & Multicomponent Collection Systems, Cell Processing Systems & Cell Expansion Systems, Auto Transfusion Devices, Others], Disposables & Consumables; By End-user: Hospitals, Blood Banks, Biotechnology & Pharmaceutical Companies, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years.

Market Dynamics

The worldwide transfusion technology market is described by an expansion in the occurrence of incessant sicknesses over the world. The market is growing at a fast pace, because of execution of government rules about security of transfusion. The worldwide transfusion technology market is anticipated to extend at a fast pace from 2018 to 2026.

Expanding number of clinical medical procedures, and creating medicinal services foundation are required to fuel the worldwide transfusion technology market amid the figure time frame. North America is probably going to represent a noteworthy offer of the worldwide market amid the conjecture time frame, inferable from strong nearness of real players with set up dissemination arranges in the area. The transfusion technology market in Asia Pacific is anticipated to extend at a high CAGR from 2018 to 2026.

Market Insights

Increment in the geriatric populace, which is inclined to chronic diseases, expansive patient pool in developing nations requiring better health care facilities, and ventures by open and private players in R&D on transfusion innovation to guarantee end of transfusion-related diseases and diminish the danger of transfusion responses are key factors that are probably going to drive the worldwide transfusion innovation market amid the figure time frame. In any case, lengthy process of obtaining regulatory approval, huge ventures required in the development of transfusion innovation, and increment in negligibly obtrusive system that prompts low blood loss are probably going to limit the worldwide market amid the conjecture time frame. Transfusion technology devices are picking up notoriety among health care professionals, as these have ended up being viable in decreasing transfusion response. Rising investment for advancement in transfusion innovation and organizations for co-improvement and commercialization of these gadgets are relied upon to fuel the worldwide transfusion technology market sooner rather than later.

Market Segmentation

Market By Product

  • Instruments
    • Apheresis System & Multicomponent Collection Systems
    • Cell Processing Systems & Cell Expansion Systems
    • Auto Transfusion Devices
    • Others
  • Disposables & Consumables

Market By End-user

  • Hospitals
  • Blood Banks
  • Biotechnology & Pharmaceutical Companies
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America and Europe represented a huge offer of the worldwide transfusion technology market in 2017. This can be credited to high health care expenditure, high rate of apheresis for treatment of chronic diseases, for example, chronic kidney disease, driven by increment in the commonness of way of life related infections, rise in mindfulness about importance of careful blood, high market penetration of recently created transfusion technology gadgets, favourable reimbursement policies guaranteeing business development for new market contestants, and nearness of real players in the two areas. Notwithstanding, changes in repayment and protection approaches in 2017 and stringent administrative system for generation of medical gadgets in the U.S. are probably going to hamper the transfusion technology market in North America in the following couple of years.

Asia Pacific is probably going to offer noteworthy chances to the transfusion technology market amid the figure time frame, attributable to an expansion in the geriatric populace, ascend in the appropriation of transfusion technology gadgets driven by mindfulness about their focal points, and flood in the occurrence of transfusion- acquired infections in the area.

Market Participants

LivaNova PLC., Haemonetics Corporation, Inc., Medtronic plc, TERUMO BCT, Asahi Kasei Medical Co., Ltd., MiltenyiBiotec, B. Braun Melsungen AG, GE Healthcare, Cerus Corporation, and Fresenius Kabi AG (Fresenius SE & Co. KGaA) are key companies catering in the global transfusion technology market.


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary